| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |